Cargando…
Association Between Metformin Use and the Risk, Prognosis of Gynecologic Cancer
BACKGROUND: For gynecological cancer patients, the beneficial effect of metformin use remains controversial due to inconsistent results of published articles. By conducting a meta-analysis, we aimed to evaluate the effect of metformin in reducing the risk and improving the survival of gynecological...
Autores principales: | Yao, Kui, Zheng, Heng, Li, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309370/ https://www.ncbi.nlm.nih.gov/pubmed/35898873 http://dx.doi.org/10.3389/fonc.2022.942380 |
Ejemplares similares
-
Common Multiple Primary Cancers Associated With Breast and Gynecologic Cancers and Their Risk Factors, Pathogenesis, Treatment and Prognosis: A Review
por: Ge, Shuwen, et al.
Publicado: (2022) -
Association between sarcopenia and survival in patients with gynecologic cancer: A systematic review and meta-analysis
por: Lin, Wen-Li, et al.
Publicado: (2023) -
Research progress of LINE-1 in the diagnosis, prognosis, and treatment of gynecologic tumors
por: Fu, Jiaojiao, et al.
Publicado: (2023) -
Zinc deficiency is associated with gynecologic cancer recurrence
por: Nakanishi, Kazuho, et al.
Publicado: (2022) -
Metformin: A Bridge between Diabetes and Prostate Cancer
por: Zingales, Veronica, et al.
Publicado: (2017)